Narayana Hrudayalaya Q1 Review - Steady Quarter Despite Significant Covid-19 Influence: ICICI Direct
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Direct Report
Narayana Hrudayalaya Ltd. posted stable QoQ results, better than our estimates across all fronts.
Revenues grew 2.6% QoQ to Rs 859.8 crore.
On the Ebitda front, margins declined 133 basis points QoQ to 15.5% amid higher employee expenditure.
Subsequently, Ebitda de-grew 5.5% QoQ to Rs 133.7 crore.
Adjusted profit after tax for the quarter was at Rs 76.2 crore with 12% QoQ growth.
Despite Covid-19 related challenges, Narayana Hrudayalaya posted a steady operational performance.
New hospitals continue to see a reduction in losses due to ramp up in occupancies.
The improvement in numbers over the last few quarters is on the back of judicious case mix identification (more focus on oncology, transplants and non-invasive procedures).
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.